Oncocyte Signs Leading Transplant Centers in US and Germany
IRVINE, Calif., Oct. 02, 2024 – PRISM MediaWire – Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that its
IRVINE, Calif., Oct. 02, 2024 – PRISM MediaWire – Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that its
Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories IRVINE, Calif., Oct. 02, 2024 – Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or
Will Provide Fund Management Services for TAG’s Innovative PPAs and Service and Monetize TAG Loan Portfolios and Investment Tax Credits Scottsdale, AZ, October 1, 2024
Premier Fortifies its Pathway to Full-Scale, High-Quality Graphene Production, with the Most Critical Raw Material/Component – High-Quality Hemp, at Low Cost EL CENTRO, Calif., October
NEW YORK, Oct 1, 2024 – PRISM MediaWire – JP 3E Holdings, Inc. (OTC: SPZI), through its wholly owned subsidiary, JP Energy Global, PTE, LTD,
Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System Jackson Center, PA, October 1, 2024 – PRISM MediaWire
Renowned Biotech Leader to Contribute Expertise in Neuroscience and Therapeutics Development New York, NY, September 30, 2024 – PRISM MediaWire – Klotho Neurosciences, Inc. (NASDAQ:
NEW YORK, Sept. 30, 2024 – PRISM MediaWire – JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., has achieved another major milestone by completing
BOCA RATON, FL, September 27, 2024 – PRISM MediaWire – SMC Entertainment, Inc. (“SMC” or the “Company”) (OTC: SMCE), an incubator company focused on acquisition
Cutting-Edge Gear to Empower Athletes in the Ultimate Endurance Challenge Strategic Alliance Unites Innovation and Performance for Unprecedented Racing Success Santa Barbara, September 26, 2024
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850